A fact sheet that provides an overview of how the immune system functions and describes the actions
of biological therapies, such as monoclonal antibodies, cytokines, therapeutic vaccines, the bacterium bacillus Calmet - Guérin, cancer - killing viruses, gene therapy, and adoptive T - cell transfer.
Maini's work as a rheumatologist has made dramatic improvement in the quality of life of sufferers of rheumatoid arthritis through the development
of the biological therapy, anti-TNF.
Not exact matches
And a third, different kind
of gene
therapy from Spark Therapeutics — to treat a rare inherited form
of blindness — is likely to be approved by the end
of 2017, too, making this year a landmark for treatments that manipulate the body's own
biological mechanisms in novel new ways to fight deadly diseases.
Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell
therapy technologies, HLI is building the world's most comprehensive database
of human genotypes and phenotypes as a basis for a variety
of commercialization opportunities to help solve aging related disease and human
biological decline.
Unlike many clinical trials that emphasize relief
of symptoms as their primary objective, the ezogabine study's goal is to gauge how well the
therapy addresses some
of the
biological underpinnings
of depression — in this case, whether the drug lessens the hyperactivity
of the reward circuit that includes VTA neurons.
Steve: So that if the underlying
biological situation seems to be a dearth
of GABA receptors, perhaps a
therapy that increases, that amps up the levels
of the GABA receptors might be efficacious?
The outcomes
of this work open new avenues
of research with the goal
of elucidating the
biological mechanisms underlying asthma in relationship with environmental exposures and to promote the development
of new
therapies.
«Our results suggest that we've been looking at these cancer drugs the wrong way — as tumour - targeting drugs — instead
of what we now feel is their most important
biological role: as immune stimulating
therapy.»
The
biological complexity
of cancer and other diseases demands a more formidable arsenal
of therapies than currently available.
«Our study reveals a new mechanism that could be harnessed for
biological therapies for lupus and other autoimmune diseases, where the immune system mistakenly targets the body's own cells,» says senior study author Boris Reizis, PhD, professor
of Pathology and Medicine at NYU Langone.
Ultimately the aim is to better understand the psychological and
biological effects
of treatment — in order to develop more effective
therapies.
After decades
of hopes raised and dashed, pediatricians, immunologists, and others are cautiously hopeful that new
biological insights and a push for treatment from parents - to - be could turn the tide for prenatal stem cell
therapy.
This matters for the optimisation
of ion - beam cancer
therapy, which requires a thorough understanding
of the relation between the physical characteristics
of the incoming ion beam and its effects on
biological tissues.
«We are joining everyone who spends their days thinking about preventing cancer, about better understanding its
biological basis, about bringing early detection and education to all communities, about developing new treatments and
therapies and about caring for patients and their families through some
of the hardest days anyone faces.»
The journal's home page explains that translational medicine «builds on basic research advances — studies
of biological processes using cell cultures, for example, or animal models — and uses them to develop new
therapies or medical procedures.»
«The paper by Dunsmoor and colleagues highlights that we are still learning important information about how to maintain the benefits
of cognitive behavioral
therapy,» said Dr. John Krystal, Editor
of Biological Psychiatry.
At a meeting last week
of the International Society for
Biological Therapy of Cancer in San Diego, California, Oncolytics Biotech
of Calgary in Alberta, Canada, reported positive results from two trials
of its drug Reolysin, which contains reovirus.
Learning more about the genes and
biological processes may guide the development
of weight - loss
therapies, and help doctors tailor the health advice they give to patients.
«Science is pleased to partner with Sartorius to recognize leading work in the rapidly developing fields
of regenerative medicine and cell
therapy», said Science Editor - in - Chief Jeremy Berg, «These fields and the inaugural awardee review how decades
of work on basic
biological mechanisms might be harnessed to yield new
therapies.»
The new Salk tool, called CasRx, opens up the vast potential
of RNA and proteins to genetic engineering, giving researchers a powerful way to develop new gene
therapies as well as investigate fundamental
biological functions.
Researchers were able to access CSF samples from the deprenyl and tocopherol antioxidative
therapy of Parkinsonism (DATATOP) study, which is the largest cohort assembled to date with longitudinal collection
of biological fluids and clinical data from PD patients.
«Learning more about the
biological impact
of the HOXA5 protein, which is absent so frequently in breast cancers, may eventually help scientists develop new
therapies to treat this disease,» says Sukumar.
«This camera has the potential to greatly enhance our understanding
of very fast
biological interactions and chemical processes that will allow us to build better models
of complex, dynamical systems such as cellular respiration, or to help doctors better deliver and monitor light - based
therapies,» says Richard Conroy, Ph.D., program director for Optical Imaging at NIBIB.
For people, substitution
therapies, which include slow acting opioids (methadone), opioids that produce a partial
biological response (buprenorphine) or antagonists that block the opioid receptor (naloxone), are the only available treatments for opioid addiction are often leading to high rates
of relapse.
Their findings could help to improve breast cancer prevention by targeting these specific
biological mechanisms with cancer
therapies in at risk patients and potentially lead the way for a new strategy for the use
of preventative treatments.
The next step will be to optimize the approach and to extend it to protein - protein interactions, protein - gene interactions, disease - protein interactions, disease - drug interactions all with a view to improving diagnostics and tailoring
therapy for the individual patient based on the outcomes
of their personal
biological network analysis.
CRISPR - Cas9 has supercharged
biological research in a mere six years, speeding up exploration
of the causes
of disease and sparking many potential new
therapies.
Next Wave asked: If research on gene vectors can be used not only to further gene
therapy but also — potentially — to aid in the development
of biological weapons, should scientists be concerned about the potential applications
of their research in genetics (as Joseph Rotblat suggested in a 19 Nov 1999 editorial in Science magazine?)
Now, in a new study published in the journal Cell, scientists at the Salk Institute for
Biological Studies have discovered that a synthetic form
of vitamin D, calcipotriol (a drug already approved by the FDA for the treatment
of psoriasis), deactivates the switch governing the fibrotic response in mouse liver cells, suggesting a potential new
therapy for fibrotic diseases in humans.
In their «Editorial comment to the «NIA - AA Research Framework: Towards a
Biological Definition
of Alzheimer's Disease,»» Nina Silverberg, Ph.D., Cerise Elliott, Ph.D., Laurie Ryan, Ph.D., Eliezer Masliah, M.D., and Richard Hodes, M.D.,
of NIA point out that the Framework — in addition to improving early detection and the development
of new
therapies — could potentially «allow more precise estimates
of how many people are at risk [for or living with] Alzheimer's disease, how best to monitor response to
therapies, and how to distinguish the effects
of Alzheimer's disease from other similar pathologies.»
An improved understanding
of the
biological background
of musical aptitude can contribute new insights into, for instance, genes that affect normal brain functions, the interactions between genes and the environment and the significance
of music as a form
of therapy.
«This research shows that it is possible to promote psychological well - being in middle childhood through an integrated school - based intervention programme informed by concepts
of positive psychology and cognitive behavioural
therapy,» said first author Dr Michael Pluess from QMUL's School
of Biological and Chemical Sciences, who led the research while previously based at University
of East London.
We will next consider the methods available to analyze
biological networks, demonstrate the application
of these principles to selected problems in biology and medicine, and discuss the implications
of biological network theory as a construct for characterizing human disease and defining novel
therapies.
«The identification
of NMD's role in longevity opens the door to the development
of new
therapies to prolong lifespan,» said Kevin Strange, MDI
Biological Laboratory president.
Where research uncovers possible mechanisms for disease, those working in drug discovery can use these data to develop novel diagnostic or monitoring tools, to develop
therapies that address the
biological pathways concerned, or to develop companion diagnostics to ensure that new — or existing —
therapies are targeted at the correct subgroup
of patients.
The exploration
of the therapeutic potential
of stem cells requires the characterization
of their
biological properties, the deciphering
of the mechanisms that underlie their pluripotency and their capacity at differentiation, by the understanding
of the signals that direct their fate towards discrete cell phenotypes... Their therapeutic use requests further, in particular in the case
of substitutive
therapies, the analysis
of their capacities
of integration in injured adult tissues and
of their potential tumorigenicity, as well as the development
of original ways
of delivery.
As a result, they are
of great interest for fields such as
biological imaging, medical diagnostics, drug delivery, and gene
therapy.
BAR HARBOR, MAINE — Recent research by Sandra Rieger, Ph.D.,
of the MDI
Biological Laboratory identifying the underlying mechanisms
of peripheral neuropathy, or nerve damage, has raised the prospect that drug
therapies can be developed for the treatment
of this condition, which causes pain, numbness and / or tingling in the hands and feet.
«In particular, his approach can be thought
of as a very advanced
biological therapy for the treatment
of breast cancer; one that uses viruses, which are better recognized to cause disease, to treat human breast cancers.»
Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell
therapy technologies, HLI is building the world's most comprehensive database
of human genotypes and phenotypes as a basis for a variety
of commercialization opportunities to help solve aging related disease and human
biological decline.
LA JOLLA — Scientists at the Salk Institute for
Biological Studies have identified a key genetic switch linked to the development, progression and outcome
of cancer, a finding that may lead to new targets for cancer
therapies.
The ultimate goal is to increase the number
of new diagnostics and
therapies for patients while reducing the time and cost
of developing them, by jointly identifying and validating promising
biological targets for several diseases, including type 2 diabetes.
Researchers continue to decode the mysteries
of hematologic malignancies, and the most successful
therapies target the genetic or
biological abnormality that is spurring the growth
of cancer cells.
«We are focused on the discovery and development
of new regenerative medicine
therapies,» said Kevin Strange, Ph.D., MDI
Biological Laboratory president.
The MDI
Biological Laboratory has a partnership agreement with ARMI to promote research and education on regeneration and the development
of new
therapies to improve human health.
In March 2006, the Burnham Biomedical Research Institute (subsequently renamed the Sanford Burnham Prebys Medical Discovery Institute), the Salk Institute for
Biological Studies, The Scripps Research Institute and the UC San Diego formed San Diego Consortium for Regenerative Medicine and adopted the mission
of expanding collaborative stem cell research and translating discoveries into clinical
therapies and cures.
LA JOLLA, CA — Using a gene
therapy delivery system developed in the laboratory
of Inder Verma at the Salk Institute for
Biological Studies, an international team
of researchers successfully treated two...
By emulating
biological principles
of self assembly, organization and regulation, we are developing disruptive technology solutions for healthcare, energy, architecture, robotics, and manufacturing, which are translated into commercial products and
therapies through formation
of new startups and corporate alliances.
Simona thinks that this cell
biological approach could help make sense
of the heterogeneity
of gliomas and improve our understanding
of invasion overall: «These are key questions — we need to know how invasion is driven as it could have profound implications for
therapy».
Given the tailored inhibition
of selected genes and the added precision brought by targeted delivery systems, RNAi - based
therapies are thought to carry lower risk
of failure than traditional approaches as the
biological effects are more predictable.